LYEL Competitors & Alternatives
Compare Lyell Immunopharma Inc with similar stocks in the same industry
Biotechnology
LYEL
Main Stock$12.87
Tradestie Score
47
Market Cap
$317.95M
Revenue Growth
-0.7%
Analyst Upside
+196.4%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$11.92
|
$371.64M | - | 54 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$16.25
|
$354.45M | - | 57 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$42.84
|
$353.70M | - | 50 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.00
|
$341.56M | - | 52 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.25
|
$332.96M | - | 49 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.91
|
$328.62M | - | 50 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$15.93
|
$308.74M | - | 56 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.07
|
$304.12M | - | 52 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$19.15
|
$297.23M | - | 52 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$27.92
|
$293.03M | - | 50 | Compare |
More LYEL Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry